New Vaccine Could Help People With Multiple Food Allergies
Summary
Researchers at the Technical University of Denmark developed an experimental mRNA vaccine aimed at protecting against several food allergens with similar molecular structures. Tests in mice and laboratory samples from allergic patients showed a broad protective antibody response, but the vaccine did not fully prevent anaphylaxis in mice and has not yet been tested in human trials.Key Facts
- The vaccine uses mRNA to prompt the body to produce antibodies that recognize and block targeted allergens.
- Researchers designed it for related allergens found in foods such as peaches and some nuts.
- Healthy mice produced protective antibodies after one dose, and the response broadened after three doses given three weeks apart.
- Allergic mice developed more protective antibodies, with virtually no observed vaccine side effects.
- At the tested doses and concentrations, the vaccine did not provide complete protection against anaphylaxis.
- Antibodies from vaccinated mice prevented allergic reactions in laboratory tests using cells and blood from allergic patients.
- Researchers are refining the vaccine formulation and preparing for human trials.
- More than 220 million people worldwide have food allergies, according to United Nations figures.
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.